CN104825965A - Chinese medicinal composition for treatment of gastroenteritis - Google Patents
Chinese medicinal composition for treatment of gastroenteritis Download PDFInfo
- Publication number
- CN104825965A CN104825965A CN201510197818.1A CN201510197818A CN104825965A CN 104825965 A CN104825965 A CN 104825965A CN 201510197818 A CN201510197818 A CN 201510197818A CN 104825965 A CN104825965 A CN 104825965A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treatment of gastroenteritis. The Chinese medicinal composition is prepared from the following crude drugs by weight: 15-25 parts of Amomum villosum, 15-25 parts of hawthorn, 5-10 parts of Radix Paeoniae Alba, 10-15 parts of chicken's gizzard-membrane, 10-15 parts of mother-of-pearl, 10-15 parts of lophatherum gracile, 5-10 parts of Schisandra chinensis, 15-25 parts of citrus aurantium, 10-15 parts of Pulsatilla chinensis, 10-15 parts of astragalus, 15-25 parts of pinellia ternate, 10-15 parts of Trichosanthes kirilowii Maxim, 10-15 parts of Lonicera japonica, 10-15 parts of prepared rhizome of rehmannia, 10-15 parts of Codonopsis pilosula, 5-10 parts of Indigowoad Leaf, 5-10 parts of medicated leaven, 5-10 parts of Mangnolia officinalis, 5-10 parts of Eupatorium fortune, 5-10 parts of Humifuse Euphorbia Herb, 5-10 parts of radix bupleuri, and 5-10 parts of licorice. The Chinese medicinal composition provided by the invention has the efficacy of warming middle-jiao to dispel cold, tonifying spleen and checking diarrhea, replenishing qi and nourishing blood, and inducing astringency, can be used for treatment of acute and chronic gastroenteritis caused by various reasons, has no toxic or side effect, and has remarkable treatment effect.
Description
Technical field
The present invention relates to a kind of internal medicine Chinese medicine composition, in particular to a kind of Chinese medicine composition for the treatment of intestinal, gastritis.
Background technology
Intestinal, gastritis are a kind of commonly encountered diseases, frequently-occurring disease, though mortality rate is not high, sickness rate is high, and the chronic enteritis course of disease is the several years to many decades, the health of serious harm people.Intestinal, gastritis have acute and chronic two kinds, acute bowel, gastritis generally by improper diet, the stomach that alimentary toxicosis causes, intestinal mucosa acute inflammation.And a kind of intestinal, gastric mucosa chronic inflammatory disease that chronic intestinal, gastritis are caused by different pathogeny, sickness rate raises along with the age and raises.Chronic intestinal, gastritis can be divided into constitutional and Secondary cases two class, because Secondary cases is normal and protopathy exists simultaneously, be secondary to liver and gall diseases, cardiac insufficiency, peptic ulcer etc. more, its symptom is that the partial clinical of protopathy shows but not an independent disease, will treat protopathy during treatment simultaneously.The common nausea and vomiting of clinical manifestation, stomachache, sometimes with diarrhoea, epigastrium or umbilicus Zhou Bushi or pain, also can show as irregular paroxysmal or persistence stomachache, this can with inappetence, feel sick, abdominal distention.
Generally adopt antibiotic medicine and astringing to arrest diarrhea drug combination both at home and abroad at present, but the unsuitable long-term taking of antibiotics, improper use, causes intestinal, gastric dysbacteriosis on the contrary, causes medicamentosus diarrhea.The frequent recurrent exerbation of intestinal, gastritis, makes patient very worried, greatly have impact on the work of patient, studying and living.Empirical evidence intestinal, gastritis Western medicine are difficult to radical cure.
Intestinal, gastritis belong to the category such as the traditional Chinese medical science " stomachache ", " hypochondriac pain ", " stomachache ", " having loose bowels ".Traditional Chinese medical science aspect sees that stomach, intestinal are all burnt in place, and intercommunicate in meridians, from five elements' taste dependent territory, liver and gall belong to wood, and large intestine belongs to gold, and small intestinal belongs to fire, raw gram each other.The cause of disease of this disease, pathogenesis mostly are intemperance of taking food, taste imbalance, incoordination between the liver and stomach, stagnation of QI due to depression of the liver, weakness of the spleen and stomach, damp and hot interior life etc. to be caused middle burnt functional activity of QI being not smooth and falls ill." Plain Questions. lift a pain opinion section " say: " between the intestines and stomach, under film is former, blood must not fall apart cold-evil visitor, and little network draws urgency, therefore pain.", " Plain Questions. a numbness opinion section " say: " eating twice as usual, the intestines and stomach is wound.”。Though its cause of disease is many, its pathogeny truly has something in common, i.e. so-called " stagnation of QI and blood may bring about pain ".The hypochondriac pain cause of disease has depression of liver-QI, blood stasis is at a stop, dampness-heat in the liver and gallbladder, deficiecny of liver-YIN etc., its etiology and pathogenesis, except qi depression to blood stasis, outside straight impairing the liver gallbladder, simultaneously relevant with taste, kidney.The stomachache cause of disease has diseases caused by exogenous pathogenic factor seasonal pathogen, eating and drinking without temperance, disorder of emotion, yang-energy element empty, and pathogenesis is depression and stagnation of QI, venation numbness hinders and passages through which vital energy circulates mistake is supported.The cause of disease of having loose bowels is being invaded by exogenous pathogen, injury due to diet, disorder of emotion, weakness of the spleen and stomach, kidney yang deficiency etc., and pathogenesis is mainly not normal at spleen and stomach function.Wish to search out a kind of Chinese medicine thoroughly curing intestinal, gastric disease in conjunction with theory of Chinese medical science.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of intestinal, gastritis, warming middle-JIAO to dispel cold, invigorating the spleen to arrest diarrhea, benefiting qi and nourishing blood, restrains astringent or styptic treatment for spontaneous sweating effect, is used for the treatment of intestinal, gastritis that a variety of causes causes, patient can be improved symptom at short notice, and have no side effect, therapeutic effect is remarkable.
The concrete technical scheme of the present invention is that a kind of Chinese medicine composition for the treatment of intestinal, gastritis, comprises the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part.
Preferably, a kind of Chinese medicine composition for the treatment of intestinal, gastritis, comprises the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part.
Preferably, a kind of Chinese medicine composition for the treatment of intestinal, gastritis, comprises the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part.
Preferably, one treats intestinal, the Chinese medicine composition of gastritis, comprise the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part, Fructus Aurantii Immaturus 15-25 part, Radix Pulsatillae 10-15 part, Radix Astragali 10-15 part, Rhizoma Pinelliae 15-25 part, Fructus Trichosanthis 10-15 part, Flos Lonicerae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Radix Codonopsis 10-15 part, Folium Isatidis 5-10 part, Massa Medicata Fermentata 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Eupatorii 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Bupleuri 5-10 part, Radix Glycyrrhizae 5-10 part.
Preferably, one treats intestinal, the Chinese medicine composition of gastritis, be made up of the crude drug of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part, Fructus Aurantii Immaturus 15-25 part, Radix Pulsatillae 10-15 part, Radix Astragali 10-15 part, Rhizoma Pinelliae 15-25 part, Fructus Trichosanthis 10-15 part, Flos Lonicerae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Radix Codonopsis 10-15 part, Folium Isatidis 5-10 part, Massa Medicata Fermentata 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Eupatorii 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Bupleuri 5-10 part, Radix Glycyrrhizae 5-10 part.
Preferably, a kind of Chinese medicine composition for the treatment of intestinal, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 15 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 5 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 10 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 5 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 10 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 15 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 10 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 5 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 5 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 5 parts, 5 parts, Radix Glycyrrhizae.
Preferably, a kind of Chinese medicine composition for the treatment of intestinal, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 25 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 15 parts, Concha Margaritifera 15 parts, Herba Lophatheri 15 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 25 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 15 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 15 parts, Flos Lonicerae 15 parts, 15 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 10 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 10 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 10 parts, Radix Bupleuri 10 parts, 10 parts, Radix Glycyrrhizae.
Preferably, the Chinese medicine composition of a kind of described treatment intestinal, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 15 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 15 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 10 parts, 5 parts, Radix Glycyrrhizae.
The Chinese medicine composition of described treatment intestinal, gastritis, can adopt the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, granule etc., and especially each crude drug pulverize mix homogeneously being made capsule, to take effect orally best.
The present invention has following advantages and beneficial effect: Chinese medicine composition of the present invention has warming middle-JIAO to dispel cold, invigorating the spleen to arrest diarrhea, benefiting qi and nourishing blood, promote the production of body fluid, easing the affected liver to relieve pain, yin fluid astringing of enriching blood, with middle emergency, restrain the effects such as astringent or styptic treatment for spontaneous sweating, be used for the treatment of deficiency-cold in middle-JIAO, coldness and pain in the epigastrium, cold-damp accumulating in the interior, the diseases such as the acute chronic gastroenteritis that loose stool or have loose bowels etc. shows are that one has no side effect, good effect, the good medicine of instant effect.Clinical data shows its total effective rate up to 98.75%.
Detailed description of the invention
Embodiment 1:
Treat a Chinese medicine composition for intestinal, gastritis, be made up of the raw material of following weight portion: Fructus Amomi 15 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 5 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 10 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 5 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 10 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 15 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 10 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 5 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 5 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 5 parts, 5 parts, Radix Glycyrrhizae.
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 2:
Treat a Chinese medicine composition for intestinal, gastritis, be made up of the raw material of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 25 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 15 parts, Concha Margaritifera 15 parts, Herba Lophatheri 15 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 25 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 15 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 15 parts, Flos Lonicerae 15 parts, 15 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 10 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 10 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 10 parts, Radix Bupleuri 10 parts, 10 parts, Radix Glycyrrhizae.
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 3:
Treat a Chinese medicine composition for intestinal, gastritis, be made up of the raw material of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 15 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 15 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 10 parts, 5 parts, Radix Glycyrrhizae.
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 4: the anti-CaM antibody of Chinese medicine composition of the present invention
Experiment material
Animal: Kunming mouse, body weight 18 ± 2g, male.
Medicine: capsule prepared by the embodiment of the present invention 1, every loading amount 1g, gets capsule 's content distilled water and is mixed with the suspension that concentration is 45mg/ml and 90mg/ml during experiment; R-1132 (the hydrochloric diphenoxylate 2.5mg of every sheet, atropine sulfate 0.025mg); Folium Sennae, commercial, through being accredited as the dried leaves of cassia acutifolia Delile Cassia acutifolia Delile, be ground into fine powder except after the impurity such as defoliation stalk, during experiment, distilled water is mixed with the suspension that concentration is 8% (g/ml); Normal saline.
Method and result
Get healthy mice 48, be divided at random 4 groups (blank group, compound diphenoxylate group, high dose of the present invention and low dose group), often organize 12, lattice is raised, every Mus one lattice, laid filter paper under mouse cage, observes 2 days, has the mice of diarrhoea (muck) then to eliminate.Fasting is each treated animal gastric infusion 0.2ml/10g (blank group gives the normal saline waiting capacity) respectively after 12 hours, after 1 hour, each treated animal is all with 8% Garfields Tea suspension oral gavage 0.25ml/10g, count with by making muck under the laid mouse cage of filter paper, per hourly in 1-6 hour change paper, finally counted once to 24 hours after 7 hours, the total grain number of muck that each treated animal of observed and recorded is discharged, each group of dehumidifying excrement number of animals, the data obtained statistical method carries out t inspection, the results are shown in Table 1.
Experimental result shows, each group all can make mice discharge the minimizing of muck number to some extent, and significantly, discharge muck number in 24 hours and be starkly lower than blank group, dose-effect relationship is obvious for high and low dose group of the present invention and compound diphenoxylate group anti-diarrhea effect.Result shows that the present invention has obvious anti-diarrhea effect.
Table 1: the impact that Chinese medicine composition of the present invention is suffered from diarrhoea on Folium Sennae induced mice
| Group | Number of animals (only) | Dosage (g/kg) | Muck grain number (grain/24 hour) (X ± SD) | P value | Dehumidifying excrement (only) |
| Blank group | 12 | —— | 6.9±2.3 | —— | 12 |
| Compound diphenoxylate group | 12 | 0.01 | 3.2±2.3 | ＜0.05 | 11 |
| High dose group of the present invention | 12 | 2.0 | 0.85±1.65 | ＜0.01 | 4 |
| Low dose group of the present invention | 12 | 1.0 | 2.85±2.36 | ＜0.01 | 10 |
Embodiment 5: the antiinflammatory action of Chinese medicine composition of the present invention
Prepared by experimental drug: Aspirin Enteric-coated Tablets, and Xuzhou Enhua Pharmaceutical Industry Group Corp., Ltd produces, every sheet 50mg, and experiment is made into the concentration of 13mg/ml with 0.5% sodium carboxymethyl cellulose; The Chinese medicine composition of the embodiment of the present invention 1, capsule 's content adding distil water makes 90mg/ml concentration.
Laboratory animal: SD rat, body weight 220 ~ 300g, male and female half and half, male mice in kunming, body weight 26 ~ 30g.
Experimental technique: get healthy mice 60, be divided into 3 groups at random, often organizes 20, male and female half and half.According to " study of tcm new drug guide-pharmacology " method modeling, observe blank (normal saline), aspirin group and Chinese medicine composition group of the present invention to the impact of mice auricle swelling model, the data obtained statistical method carries out t inspection, the results are shown in Table 2.
Table 2 antiphlogistic effects of the present invention
| Group | Number of animals (only) | Dosage (g/kg) | Swelling (mg) |
| Blank | 20 | —— | 14.47±6.54 |
| Aspirin group | 20 | 0.2g | 8.25±3.25 ** |
| Chinese medicine composition group of the present invention | 20 | 2.0g | 7.68±3.25 ** |
Note: compare with blank group, * P < 0.05, * * P < 0.01
Experimental result shows that Chinese medicine composition of the present invention and aspirin group all have obvious inhibitory action to mice ear, difference has statistical significance (* * P < 0.01), shows Chinese medicine composition of the present invention and has obvious inhibitory action to acute exudative inflammation.
Embodiment 6: the vitro antibacterial activity test report of capsule of the present invention
Investigational agent: capsule prepared by the embodiment of the present invention 1
Antibacterial is used in test: staphylococcus aureus, escherichia coli, Bacillus proteus, Bacillus typhi, dysentery bacterium (preservation of microbiology teaching and research room of unming Medical College).
Test method: tube dilution method.
Result: the embodiment of the present invention 1 prepare capsule to staphylococcus aureus without antibacterial action; Be 65.05mg crude drug/ml to colibacillary minimal inhibitory concentration, be 32.12mg crude drug/ml to the minimal inhibitory concentration of Bacillus proteus, being 138.08mg crude drug/ml to Bacillus typhi minimal inhibitory concentration, is 16.83mg crude drug/ml to dysentery bacterium minimal inhibitory concentration.Illustrate that the present invention has certain antibacterial action to above-mentioned four kinds of Bacterium entericum.
Embodiment 7: the clinical observation on the therapeutic effect of Chinese medicine composition of the present invention
1, physical data
Selection of clinical patient 400 example, wherein man 300 example, female 100 example, wherein 30-40 year 100 example, 41-45 year 100 example, 46-50 year 100 example, 51-60 year 100 example.
2, diagnostic criteria
Cure: inflammation all disappears, recover normal completely, and confirmed for CT or intestinal, gastroscopy, stool shaping or one-tenth soft stool, every day 1-2 time, without mucosanguineous feces.
Effective: symptom is improved in various degree or taken a turn for the better, medication treatment need be continued.
Invalid: symptom is without any improvement or take a turn for the better, and even has development trend.
3, Therapeutic Method
Adopt the capsule made of embodiment 1, every containing crude drug 1g, every day is early, middle and late respectively takes one to patient, within 15 days, is a course for the treatment of, minimumly takes 3 courses for the treatment of.
4, therapeutic outcome
Cure 225 examples, cure rate 56.25%; Effective 170 examples, effective percentage 42.5%; Invalid 5 examples, inefficiency 1.25%.
Claims (10)
1. treat a Chinese medicine composition for intestinal, gastritis, comprise the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part.
2. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, comprises the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part.
3. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, comprises the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part.
4. treatment intestinal according to claim 1, the Chinese medicine composition of gastritis, comprise the raw material of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part, Fructus Aurantii Immaturus 15-25 part, Radix Pulsatillae 10-15 part, Radix Astragali 10-15 part, Rhizoma Pinelliae 15-25 part, Fructus Trichosanthis 10-15 part, Flos Lonicerae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Radix Codonopsis 10-15 part, Folium Isatidis 5-10 part, Massa Medicata Fermentata 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Eupatorii 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Bupleuri 5-10 part, Radix Glycyrrhizae 5-10 part.
5. treatment intestinal according to claim 1, the Chinese medicine composition of gastritis, be made up of the crude drug of following weight portion: Fructus Amomi 15-25 part, Fructus Crataegi 15-25 part, Radix Paeoniae Alba 5-10 part, Endothelium Corneum Gigeriae Galli 10-15 part, Concha Margaritifera 10-15 part, Herba Lophatheri 10-15 part, Fructus Schisandrae Chinensis 5-10 part, Fructus Aurantii Immaturus 15-25 part, Radix Pulsatillae 10-15 part, Radix Astragali 10-15 part, Rhizoma Pinelliae 15-25 part, Fructus Trichosanthis 10-15 part, Flos Lonicerae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Radix Codonopsis 10-15 part, Folium Isatidis 5-10 part, Massa Medicata Fermentata 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Eupatorii 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Bupleuri 5-10 part, Radix Glycyrrhizae 5-10 part.
6. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 15 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 5 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 10 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 5 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 10 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 15 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 10 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 10 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 5 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 5 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 5 parts, 5 parts, Radix Glycyrrhizae.
7. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 25 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 15 parts, Concha Margaritifera 15 parts, Herba Lophatheri 15 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 25 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 15 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 15 parts, Flos Lonicerae 15 parts, 15 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 10 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 10 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 10 parts, Radix Bupleuri 10 parts, 10 parts, Radix Glycyrrhizae.
8. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, is made up of the crude drug of following weight portion: Fructus Amomi 25 parts, Fructus Crataegi 15 parts, the Radix Paeoniae Alba 10 parts, Endothelium Corneum Gigeriae Galli 10 parts, Concha Margaritifera 15 parts, Herba Lophatheri 10 parts, Fructus Schisandrae Chinensis 10 parts, Fructus Aurantii Immaturus 15 parts, the Radix Pulsatillae 15 parts, the Radix Astragali 10 parts, the Rhizoma Pinelliae 25 parts, Fructus Trichosanthis 10 parts, Flos Lonicerae 15 parts, 10 parts, Radix Rehmanniae Preparata, Radix Codonopsis 15 parts, Folium Isatidis 5 parts, Massa Medicata Fermentata 10 parts, Cortex Magnoliae Officinalis 5 parts, Herba Eupatorii 10 parts, Herba Euphorbiae Humifusae 5 parts, Radix Bupleuri 10 parts, 5 parts, Radix Glycyrrhizae.
9. the Chinese medicine composition for the treatment of intestinal according to claim 1, gastritis, is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
10. the Chinese medicine composition for the treatment of intestinal according to claim 9, gastritis, is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510197818.1A CN104825965A (en) | 2015-04-24 | 2015-04-24 | Chinese medicinal composition for treatment of gastroenteritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510197818.1A CN104825965A (en) | 2015-04-24 | 2015-04-24 | Chinese medicinal composition for treatment of gastroenteritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104825965A true CN104825965A (en) | 2015-08-12 |
Family
ID=53804408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510197818.1A Pending CN104825965A (en) | 2015-04-24 | 2015-04-24 | Chinese medicinal composition for treatment of gastroenteritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104825965A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327191A (en) * | 2015-12-09 | 2016-02-17 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating damp-heat stagnant jamming type diarrhea |
| CN105381449A (en) * | 2015-12-31 | 2016-03-09 | 毛春梅 | Traditional Chinese medicine composition for treating enterogastritis |
| CN105412651A (en) * | 2015-12-09 | 2016-03-23 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating dampness-heat stagnancy type diarrhoea accompanied with abdominal pain |
| CN105796940A (en) * | 2015-12-09 | 2016-07-27 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating diarrhoea caused by summer-heat stasis |
| CN105796941A (en) * | 2015-12-09 | 2016-07-27 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating summer-heat stasis diarrhea accompanied by abdominal pain |
| CN105853605A (en) * | 2016-05-25 | 2016-08-17 | 田东县浙缘农业科技有限公司 | Traditional Chinese medicine composition for treating spleen insufficiency and qi stagnation type gastritis and preparing method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1520860A (en) * | 2003-01-28 | 2004-08-18 | 山东中医药大学 | Pharmaceutical composition for colitis |
| CN1634192A (en) * | 2003-12-30 | 2005-07-06 | 张琼芳 | Medicine for treating chronic gastroenteritis and colitis |
| CN103041282A (en) * | 2013-01-29 | 2013-04-17 | 王鹤成 | Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine |
-
2015
- 2015-04-24 CN CN201510197818.1A patent/CN104825965A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1520860A (en) * | 2003-01-28 | 2004-08-18 | 山东中医药大学 | Pharmaceutical composition for colitis |
| CN1634192A (en) * | 2003-12-30 | 2005-07-06 | 张琼芳 | Medicine for treating chronic gastroenteritis and colitis |
| CN103041282A (en) * | 2013-01-29 | 2013-04-17 | 王鹤成 | Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327191A (en) * | 2015-12-09 | 2016-02-17 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating damp-heat stagnant jamming type diarrhea |
| CN105412651A (en) * | 2015-12-09 | 2016-03-23 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating dampness-heat stagnancy type diarrhoea accompanied with abdominal pain |
| CN105796940A (en) * | 2015-12-09 | 2016-07-27 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating diarrhoea caused by summer-heat stasis |
| CN105796941A (en) * | 2015-12-09 | 2016-07-27 | 济南昊泽环保科技有限公司 | Traditional Chinese medicine for treating summer-heat stasis diarrhea accompanied by abdominal pain |
| CN105381449A (en) * | 2015-12-31 | 2016-03-09 | 毛春梅 | Traditional Chinese medicine composition for treating enterogastritis |
| CN105853605A (en) * | 2016-05-25 | 2016-08-17 | 田东县浙缘农业科技有限公司 | Traditional Chinese medicine composition for treating spleen insufficiency and qi stagnation type gastritis and preparing method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104825965A (en) | Chinese medicinal composition for treatment of gastroenteritis | |
| CN101249235B (en) | Chinese medicine for curing esophagus cancer and method of preparing the same | |
| CN102698123A (en) | Traditional Chinese medicinal composition for treating transmissible gastroenteritis of swine, feed, preparation method and application thereof | |
| CN104173937A (en) | Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof | |
| CN1970010A (en) | Chinese medicinal formulation for treating gastrointestinal disease | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN103405742B (en) | Drug composition for treating infantile diarrhea and preparation method thereof | |
| CN101972391A (en) | Medicinal composition used for treating swine mastitis and preparation method thereof | |
| CN101537037B (en) | Amaranth berberine tablet and preparation method thereof | |
| CN103055076A (en) | Pure Chinese medicinal composition for treating nosemosis of bees and preparation method of pure Chinese medicinal composition | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN105031488A (en) | Traditional Chinese medicinal composition for treating enterogastritis | |
| CN102526639B (en) | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof | |
| CN105213854A (en) | Agent raised by the Chinese medicine of a kind of prophylactic treatment chicken rabbit diarrhoea and yellow urine disease | |
| US20130202723A1 (en) | Method of producing a chinese herbal composition for treating terminal cancer patients with constipation | |
| CN101095868A (en) | Medicine composition for treating colitis and method of making the same | |
| CN101401903B (en) | Chinese medicinal composition for treating endometritis of cow | |
| CN103816265B (en) | A kind ofly be used for the treatment of medicine of having loose bowels and preparation method thereof | |
| CN104547125A (en) | Gastrointestinal drug and application thereof | |
| CN110538218A (en) | Composition for treating mastitis | |
| CN105396107A (en) | Traditional Chinese medicine composition for curing gastroenteritis | |
| CN108030847A (en) | A kind of pharmaceutical composition for treating constipation and its application | |
| CN103127461B (en) | Pharmaceutical composition capable of curing chronic gastritis, preparation method and new application thereof | |
| CN102961732B (en) | The composition and method of making the same for the treatment of rabbit enteritis | |
| CN103100061B (en) | Medicinal composition for treating chronic gastritis and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |
|
| WD01 | Invention patent application deemed withdrawn after publication |